---
title: 'Immunotherapeutic Strategies for the Treatment of Glioblastoma: Current Challenges
  and Future Perspectives'
date: '2024-04-13'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/38610954/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&fc=20220326224207&ff=20240413180704&v=2.18.0.post9+e462414
source: heidelberg[Affiliation]
description: Despite decades of research and the best up-to-date treatments, grade
  4 Glioblastoma (GBM) remains uniformly fatal with a patient median overall survival
  of less than 2 years. Recent advances in immunotherapy have reignited interest in
  utilizing immunological approaches to fight cancer. However, current immunotherapies
  have so far not met the anticipated expectations, achieving modest results in their
  journey from bench to bedside for the treatment of GBM. Understanding the intrinsic
  features ...
disable_comments: true
---
Despite decades of research and the best up-to-date treatments, grade 4 Glioblastoma (GBM) remains uniformly fatal with a patient median overall survival of less than 2 years. Recent advances in immunotherapy have reignited interest in utilizing immunological approaches to fight cancer. However, current immunotherapies have so far not met the anticipated expectations, achieving modest results in their journey from bench to bedside for the treatment of GBM. Understanding the intrinsic features ...